nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—CYP3A4—Sibutramine—obesity	0.101	0.27	CbGbCtD
Dantrolene—RYR3—diaphragm—obesity	0.0992	0.624	CbGeAlD
Dantrolene—CYP3A4—Benzphetamine—obesity	0.0769	0.204	CbGbCtD
Dantrolene—CYP3A4—Bupropion—obesity	0.0653	0.174	CbGbCtD
Dantrolene—CYP3A4—Orlistat—obesity	0.0533	0.142	CbGbCtD
Dantrolene—CYP3A4—Cimetidine—obesity	0.048	0.127	CbGbCtD
Dantrolene—CYP3A4—Topiramate—obesity	0.0314	0.0834	CbGbCtD
Dantrolene—RYR3—cardiovascular system—obesity	0.00868	0.0546	CbGeAlD
Dantrolene—RYR3—pituitary gland—obesity	0.00768	0.0484	CbGeAlD
Dantrolene—RYR3—adipose tissue—obesity	0.00765	0.0482	CbGeAlD
Dantrolene—RYR3—digestive system—obesity	0.0072	0.0453	CbGeAlD
Dantrolene—RYR3—adrenal gland—obesity	0.00686	0.0432	CbGeAlD
Dantrolene—RYR1—cardiovascular system—obesity	0.00623	0.0392	CbGeAlD
Dantrolene—RYR1—adrenal gland—obesity	0.00492	0.031	CbGeAlD
Dantrolene—RYR1—endocrine gland—obesity	0.00427	0.0269	CbGeAlD
Dantrolene—RYR1—liver—obesity	0.00385	0.0242	CbGeAlD
Dantrolene—Nitrazepam—GABRA6—obesity	0.00154	0.787	CrCbGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—FTL—obesity	0.000916	0.00581	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—GABRA6—obesity	0.000916	0.00581	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—ADRB2—obesity	0.000903	0.00573	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC27A1—obesity	0.000902	0.00573	CbGpPWpGaD
Dantrolene—CYP3A4—digestive system—obesity	0.000898	0.00565	CbGeAlD
Dantrolene—Hypersensitivity—Phenylpropanolamine—obesity	0.00089	0.00292	CcSEcCtD
Dantrolene—Headache—Phendimetrazine—obesity	0.000886	0.0029	CcSEcCtD
Dantrolene—Dyspepsia—Diethylpropion—obesity	0.000885	0.0029	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC6A14—obesity	0.000878	0.00557	CbGpPWpGaD
Dantrolene—Musculoskeletal discomfort—Cimetidine—obesity	0.000872	0.00286	CcSEcCtD
Dantrolene—Lacrimation increased—Topiramate—obesity	0.000864	0.00283	CcSEcCtD
Dantrolene—Urinary retention—Bupropion—obesity	0.000862	0.00282	CcSEcCtD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—GNB3—obesity	0.00086	0.00546	CbGpPWpGaD
Dantrolene—Constipation—Diethylpropion—obesity	0.00086	0.00282	CcSEcCtD
Dantrolene—Nocturia—Topiramate—obesity	0.000858	0.00281	CcSEcCtD
Dantrolene—Somnolence—Cimetidine—obesity	0.000851	0.00279	CcSEcCtD
Dantrolene—Nausea—Phendimetrazine—obesity	0.00084	0.00275	CcSEcCtD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—PRKCB—obesity	0.00084	0.00533	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—GNAS—obesity	0.000838	0.00532	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—GNB3—obesity	0.000834	0.00529	CbGpPWpGaD
Dantrolene—Pollakiuria—Sibutramine—obesity	0.000831	0.00272	CcSEcCtD
Dantrolene—Asthenia—Phentermine—obesity	0.00083	0.00272	CcSEcCtD
Dantrolene—Feeling abnormal—Diethylpropion—obesity	0.000829	0.00271	CcSEcCtD
Dantrolene—Depression—Orlistat—obesity	0.000826	0.00271	CcSEcCtD
Dantrolene—Fatigue—Cimetidine—obesity	0.000825	0.0027	CcSEcCtD
Dantrolene—Atrioventricular block—Topiramate—obesity	0.000821	0.00269	CcSEcCtD
Dantrolene—Constipation—Cimetidine—obesity	0.000818	0.00268	CcSEcCtD
Dantrolene—Renal failure—Orlistat—obesity	0.000814	0.00267	CcSEcCtD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—PRKCB—obesity	0.000814	0.00516	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—GNAS—obesity	0.000812	0.00515	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—STS—obesity	0.000801	0.00509	CbGpPWpGaD
Dantrolene—Muscular weakness—Bupropion—obesity	0.0008	0.00262	CcSEcCtD
Dantrolene—Depression—Sibutramine—obesity	0.000799	0.00262	CcSEcCtD
Dantrolene—Urticaria—Diethylpropion—obesity	0.000799	0.00262	CcSEcCtD
Dantrolene—Dizziness—Phenylpropanolamine—obesity	0.000799	0.00262	CcSEcCtD
Dantrolene—Diarrhoea—Phentermine—obesity	0.000791	0.00259	CcSEcCtD
Dantrolene—Feeling abnormal—Cimetidine—obesity	0.000789	0.00258	CcSEcCtD
Dantrolene—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—obesity	0.000788	0.005	CbGpPWpGaD
Dantrolene—Renal failure—Sibutramine—obesity	0.000788	0.00258	CcSEcCtD
Dantrolene—Dysphagia—Bupropion—obesity	0.000784	0.00257	CcSEcCtD
Dantrolene—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—obesity	0.000772	0.0049	CbGpPWpGaD
Dantrolene—Urinary incontinence—Topiramate—obesity	0.000769	0.00252	CcSEcCtD
Dantrolene—Sweating—Sibutramine—obesity	0.000769	0.00252	CcSEcCtD
Dantrolene—Vomiting—Phenylpropanolamine—obesity	0.000768	0.00252	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—TRPV1—obesity	0.000767	0.00487	CbGpPWpGaD
Dantrolene—Dizziness—Phentermine—obesity	0.000765	0.0025	CcSEcCtD
Dantrolene—Haematuria—Sibutramine—obesity	0.000764	0.0025	CcSEcCtD
Dantrolene—Rash—Phenylpropanolamine—obesity	0.000762	0.0025	CcSEcCtD
Dantrolene—Dermatitis—Phenylpropanolamine—obesity	0.000761	0.00249	CcSEcCtD
Dantrolene—Body temperature increased—Cimetidine—obesity	0.000757	0.00248	CcSEcCtD
Dantrolene—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—obesity	0.000748	0.00475	CbGpPWpGaD
Dantrolene—Haemoglobin—Orlistat—obesity	0.000747	0.00245	CcSEcCtD
Dantrolene—Hepatitis—Orlistat—obesity	0.000744	0.00244	CcSEcCtD
Dantrolene—Haemorrhage—Orlistat—obesity	0.000744	0.00244	CcSEcCtD
Dantrolene—CYP3A4—endocrine gland—obesity	0.000742	0.00467	CbGeAlD
Dantrolene—RYR3—Transmembrane transport of small molecules—HK1—obesity	0.000739	0.00469	CbGpPWpGaD
Dantrolene—Vomiting—Phentermine—obesity	0.000735	0.00241	CcSEcCtD
Dantrolene—Rash—Phentermine—obesity	0.000729	0.00239	CcSEcCtD
Dantrolene—Dermatitis—Phentermine—obesity	0.000728	0.00239	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC9A3—obesity	0.000727	0.00462	CbGpPWpGaD
Dantrolene—Headache—Phentermine—obesity	0.000724	0.00237	CcSEcCtD
Dantrolene—Pollakiuria—Bupropion—obesity	0.000724	0.00237	CcSEcCtD
Dantrolene—Haemoglobin—Sibutramine—obesity	0.000723	0.00237	CcSEcCtD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—PRKCD—obesity	0.000722	0.00458	CbGpPWpGaD
Dantrolene—Haemorrhage—Sibutramine—obesity	0.00072	0.00236	CcSEcCtD
Dantrolene—Nausea—Phenylpropanolamine—obesity	0.000718	0.00235	CcSEcCtD
Dantrolene—Hypersensitivity—Cimetidine—obesity	0.000705	0.00231	CcSEcCtD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—PRKCD—obesity	0.000699	0.00444	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—HK2—obesity	0.000694	0.0044	CbGpPWpGaD
Dantrolene—Visual impairment—Sibutramine—obesity	0.000694	0.00227	CcSEcCtD
Dantrolene—CYP3A4—Liver X Receptor Pathway—SREBF1—obesity	0.000692	0.0044	CbGpPWpGaD
Dantrolene—Diarrhoea—Diethylpropion—obesity	0.000688	0.00225	CcSEcCtD
Dantrolene—Nausea—Phentermine—obesity	0.000687	0.00225	CcSEcCtD
Dantrolene—Asthenia—Cimetidine—obesity	0.000687	0.00225	CcSEcCtD
Dantrolene—RYR3—Alzheimers Disease—TNF—obesity	0.000684	0.00434	CbGpPWpGaD
Dantrolene—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—obesity	0.000684	0.00434	CbGpPWpGaD
Dantrolene—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—obesity	0.000684	0.00434	CbGpPWpGaD
Dantrolene—Phlebitis—Topiramate—obesity	0.000671	0.0022	CcSEcCtD
Dantrolene—Sweating—Bupropion—obesity	0.00067	0.00219	CcSEcCtD
Dantrolene—CYP3A4—liver—obesity	0.000669	0.00421	CbGeAlD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC27A1—obesity	0.000665	0.00422	CbGpPWpGaD
Dantrolene—Dizziness—Diethylpropion—obesity	0.000665	0.00218	CcSEcCtD
Dantrolene—CYP3A4—Liver X Receptor Pathway—FASN—obesity	0.000659	0.00418	CbGpPWpGaD
Dantrolene—Diarrhoea—Cimetidine—obesity	0.000655	0.00214	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC22A1—obesity	0.000652	0.00414	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—NOS3—obesity	0.000646	0.0041	CbGpPWpGaD
Dantrolene—Chills—Sibutramine—obesity	0.000646	0.00212	CcSEcCtD
Dantrolene—Hepatic failure—Topiramate—obesity	0.000643	0.00211	CcSEcCtD
Dantrolene—Vomiting—Diethylpropion—obesity	0.00064	0.00209	CcSEcCtD
Dantrolene—Rash—Diethylpropion—obesity	0.000634	0.00208	CcSEcCtD
Dantrolene—Dysgeusia—Orlistat—obesity	0.000634	0.00208	CcSEcCtD
Dantrolene—Dermatitis—Diethylpropion—obesity	0.000634	0.00208	CcSEcCtD
Dantrolene—Dizziness—Cimetidine—obesity	0.000633	0.00207	CcSEcCtD
Dantrolene—Haemoglobin—Bupropion—obesity	0.000631	0.00207	CcSEcCtD
Dantrolene—Headache—Diethylpropion—obesity	0.00063	0.00206	CcSEcCtD
Dantrolene—Haemorrhage—Bupropion—obesity	0.000627	0.00206	CcSEcCtD
Dantrolene—Hepatitis—Bupropion—obesity	0.000627	0.00206	CcSEcCtD
Dantrolene—Back pain—Orlistat—obesity	0.000626	0.00205	CcSEcCtD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—PRKCB—obesity	0.000619	0.00393	CbGpPWpGaD
Dantrolene—Tension—Sibutramine—obesity	0.000615	0.00201	CcSEcCtD
Dantrolene—Dysgeusia—Sibutramine—obesity	0.000614	0.00201	CcSEcCtD
Dantrolene—Vision blurred—Orlistat—obesity	0.00061	0.002	CcSEcCtD
Dantrolene—Visual disturbance—Topiramate—obesity	0.00061	0.002	CcSEcCtD
Dantrolene—Nervousness—Sibutramine—obesity	0.000609	0.00199	CcSEcCtD
Dantrolene—Vomiting—Cimetidine—obesity	0.000609	0.00199	CcSEcCtD
Dantrolene—Back pain—Sibutramine—obesity	0.000606	0.00199	CcSEcCtD
Dantrolene—Visual impairment—Bupropion—obesity	0.000605	0.00198	CcSEcCtD
Dantrolene—Rash—Cimetidine—obesity	0.000603	0.00198	CcSEcCtD
Dantrolene—Dermatitis—Cimetidine—obesity	0.000603	0.00197	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—PRKAR2B—obesity	0.000602	0.00382	CbGpPWpGaD
Dantrolene—Ill-defined disorder—Orlistat—obesity	0.000601	0.00197	CcSEcCtD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—PRKCB—obesity	0.0006	0.00381	CbGpPWpGaD
Dantrolene—Headache—Cimetidine—obesity	0.0006	0.00196	CcSEcCtD
Dantrolene—Nausea—Diethylpropion—obesity	0.000597	0.00196	CcSEcCtD
Dantrolene—Vision blurred—Sibutramine—obesity	0.00059	0.00193	CcSEcCtD
Dantrolene—Malaise—Orlistat—obesity	0.000584	0.00191	CcSEcCtD
Dantrolene—Flushing—Bupropion—obesity	0.000582	0.00191	CcSEcCtD
Dantrolene—Ill-defined disorder—Sibutramine—obesity	0.000581	0.0019	CcSEcCtD
Dantrolene—Anaemia—Sibutramine—obesity	0.000579	0.0019	CcSEcCtD
Dantrolene—Pain in extremity—Topiramate—obesity	0.000578	0.00189	CcSEcCtD
Dantrolene—Diplopia—Topiramate—obesity	0.000578	0.00189	CcSEcCtD
Dantrolene—Nausea—Cimetidine—obesity	0.000568	0.00186	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—GCK—obesity	0.000567	0.0036	CbGpPWpGaD
Dantrolene—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—obesity	0.000567	0.0036	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—TRPV1—obesity	0.000566	0.00359	CbGpPWpGaD
Dantrolene—Malaise—Sibutramine—obesity	0.000565	0.00185	CcSEcCtD
Dantrolene—Chills—Bupropion—obesity	0.000563	0.00184	CcSEcCtD
Dantrolene—Convulsion—Orlistat—obesity	0.000561	0.00184	CcSEcCtD
Dantrolene—Leukopenia—Sibutramine—obesity	0.000561	0.00184	CcSEcCtD
Dantrolene—Myalgia—Orlistat—obesity	0.000551	0.00181	CcSEcCtD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IL1B—obesity	0.00055	0.00349	CbGpPWpGaD
Dantrolene—Urinary retention—Topiramate—obesity	0.000549	0.0018	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—CETP—obesity	0.000547	0.00347	CbGpPWpGaD
Dantrolene—Discomfort—Orlistat—obesity	0.000545	0.00178	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—HK1—obesity	0.000545	0.00346	CbGpPWpGaD
Dantrolene—Convulsion—Sibutramine—obesity	0.000543	0.00178	CcSEcCtD
Dantrolene—Hypertension—Sibutramine—obesity	0.000541	0.00177	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—TF—obesity	0.000541	0.00343	CbGpPWpGaD
Dantrolene—Dry mouth—Orlistat—obesity	0.000539	0.00177	CcSEcCtD
Dantrolene—Tension—Bupropion—obesity	0.000536	0.00176	CcSEcCtD
Dantrolene—Dysgeusia—Bupropion—obesity	0.000535	0.00175	CcSEcCtD
Dantrolene—Myalgia—Sibutramine—obesity	0.000533	0.00175	CcSEcCtD
Dantrolene—Nervousness—Bupropion—obesity	0.000531	0.00174	CcSEcCtD
Dantrolene—Anaphylactic shock—Orlistat—obesity	0.000528	0.00173	CcSEcCtD
Dantrolene—Back pain—Bupropion—obesity	0.000528	0.00173	CcSEcCtD
Dantrolene—Discomfort—Sibutramine—obesity	0.000527	0.00173	CcSEcCtD
Dantrolene—Dry mouth—Sibutramine—obesity	0.000522	0.00171	CcSEcCtD
Dantrolene—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—obesity	0.000518	0.00329	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—TFRC—obesity	0.000518	0.00329	CbGpPWpGaD
Dantrolene—Confusional state—Sibutramine—obesity	0.000516	0.00169	CcSEcCtD
Dantrolene—Vision blurred—Bupropion—obesity	0.000515	0.00169	CcSEcCtD
Dantrolene—Anaphylactic shock—Sibutramine—obesity	0.000511	0.00167	CcSEcCtD
Dantrolene—Hyperhidrosis—Orlistat—obesity	0.000511	0.00167	CcSEcCtD
Dantrolene—Muscular weakness—Topiramate—obesity	0.00051	0.00167	CcSEcCtD
Dantrolene—Ill-defined disorder—Bupropion—obesity	0.000507	0.00166	CcSEcCtD
Dantrolene—Anaemia—Bupropion—obesity	0.000505	0.00165	CcSEcCtD
Dantrolene—CYP3A4—Irinotecan Pathway—BCHE—obesity	0.000502	0.00318	CbGpPWpGaD
Dantrolene—Thrombocytopenia—Sibutramine—obesity	0.000501	0.00164	CcSEcCtD
Dantrolene—Dysphagia—Topiramate—obesity	0.000499	0.00164	CcSEcCtD
Dantrolene—Tachycardia—Sibutramine—obesity	0.000499	0.00163	CcSEcCtD
Dantrolene—Eosinophilia—Topiramate—obesity	0.000495	0.00162	CcSEcCtD
Dantrolene—Hyperhidrosis—Sibutramine—obesity	0.000494	0.00162	CcSEcCtD
Dantrolene—Malaise—Bupropion—obesity	0.000493	0.00161	CcSEcCtD
Dantrolene—Leukopenia—Bupropion—obesity	0.000489	0.0016	CcSEcCtD
Dantrolene—Anorexia—Sibutramine—obesity	0.000487	0.0016	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Orlistat—obesity	0.000481	0.00158	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC22A1—obesity	0.000481	0.00305	CbGpPWpGaD
Dantrolene—CYP3A4—Tamoxifen metabolism—SULT2A1—obesity	0.000478	0.00304	CbGpPWpGaD
Dantrolene—Insomnia—Orlistat—obesity	0.000478	0.00157	CcSEcCtD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—NOS3—obesity	0.000477	0.00302	CbGpPWpGaD
Dantrolene—Convulsion—Bupropion—obesity	0.000473	0.00155	CcSEcCtD
Dantrolene—Hypertension—Bupropion—obesity	0.000472	0.00154	CcSEcCtD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARD—obesity	0.000471	0.00299	CbGpPWpGaD
Dantrolene—Musculoskeletal discomfort—Sibutramine—obesity	0.000466	0.00153	CcSEcCtD
Dantrolene—Dyspepsia—Orlistat—obesity	0.000465	0.00152	CcSEcCtD
Dantrolene—Myalgia—Bupropion—obesity	0.000465	0.00152	CcSEcCtD
Dantrolene—Insomnia—Sibutramine—obesity	0.000463	0.00151	CcSEcCtD
Dantrolene—Pollakiuria—Topiramate—obesity	0.000461	0.00151	CcSEcCtD
Dantrolene—Discomfort—Bupropion—obesity	0.000459	0.0015	CcSEcCtD
Dantrolene—Decreased appetite—Orlistat—obesity	0.000459	0.0015	CcSEcCtD
Dantrolene—Fatigue—Orlistat—obesity	0.000456	0.00149	CcSEcCtD
Dantrolene—Dry mouth—Bupropion—obesity	0.000455	0.00149	CcSEcCtD
Dantrolene—Somnolence—Sibutramine—obesity	0.000455	0.00149	CcSEcCtD
Dantrolene—Pain—Orlistat—obesity	0.000452	0.00148	CcSEcCtD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—obesity	0.000451	0.00286	CbGpPWpGaD
Dantrolene—Dyspepsia—Sibutramine—obesity	0.00045	0.00147	CcSEcCtD
Dantrolene—Confusional state—Bupropion—obesity	0.000449	0.00147	CcSEcCtD
Dantrolene—Anaphylactic shock—Bupropion—obesity	0.000446	0.00146	CcSEcCtD
Dantrolene—Decreased appetite—Sibutramine—obesity	0.000445	0.00146	CcSEcCtD
Dantrolene—Depression—Topiramate—obesity	0.000444	0.00145	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—PRKAR2B—obesity	0.000444	0.00282	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC2A4—obesity	0.000441	0.0028	CbGpPWpGaD
Dantrolene—Renal failure—Topiramate—obesity	0.000438	0.00143	CcSEcCtD
Dantrolene—Pain—Sibutramine—obesity	0.000437	0.00143	CcSEcCtD
Dantrolene—Constipation—Sibutramine—obesity	0.000437	0.00143	CcSEcCtD
Dantrolene—Thrombocytopenia—Bupropion—obesity	0.000436	0.00143	CcSEcCtD
Dantrolene—Feeling abnormal—Orlistat—obesity	0.000435	0.00143	CcSEcCtD
Dantrolene—Tachycardia—Bupropion—obesity	0.000435	0.00143	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—CYCS—obesity	0.000435	0.00276	CbGpPWpGaD
Dantrolene—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—obesity	0.000435	0.00276	CbGpPWpGaD
Dantrolene—Gastrointestinal pain—Orlistat—obesity	0.000432	0.00142	CcSEcCtD
Dantrolene—Hyperhidrosis—Bupropion—obesity	0.000431	0.00141	CcSEcCtD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—obesity	0.000429	0.00273	CbGpPWpGaD
Dantrolene—Anorexia—Bupropion—obesity	0.000425	0.00139	CcSEcCtD
Dantrolene—Haematuria—Topiramate—obesity	0.000425	0.00139	CcSEcCtD
Dantrolene—Feeling abnormal—Sibutramine—obesity	0.000421	0.00138	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—NCOA1—obesity	0.00042	0.00267	CbGpPWpGaD
Dantrolene—Urticaria—Orlistat—obesity	0.00042	0.00137	CcSEcCtD
Dantrolene—Gastrointestinal pain—Sibutramine—obesity	0.000418	0.00137	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—GCK—obesity	0.000418	0.00265	CbGpPWpGaD
Dantrolene—Abdominal pain—Orlistat—obesity	0.000418	0.00137	CcSEcCtD
Dantrolene—Body temperature increased—Orlistat—obesity	0.000418	0.00137	CcSEcCtD
Dantrolene—Nitrazepam—CYP2E1—obesity	0.000418	0.213	CrCbGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—PLG—obesity	0.00041	0.0026	CbGpPWpGaD
Dantrolene—Urticaria—Sibutramine—obesity	0.000406	0.00133	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Bupropion—obesity	0.000406	0.00133	CcSEcCtD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL1B—obesity	0.000406	0.00257	CbGpPWpGaD
Dantrolene—Body temperature increased—Sibutramine—obesity	0.000404	0.00132	CcSEcCtD
Dantrolene—Abdominal pain—Sibutramine—obesity	0.000404	0.00132	CcSEcCtD
Dantrolene—Insomnia—Bupropion—obesity	0.000403	0.00132	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—CETP—obesity	0.000403	0.00256	CbGpPWpGaD
Dantrolene—Haemoglobin—Topiramate—obesity	0.000402	0.00132	CcSEcCtD
Dantrolene—Hepatitis—Topiramate—obesity	0.0004	0.00131	CcSEcCtD
Dantrolene—Haemorrhage—Topiramate—obesity	0.0004	0.00131	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—TF—obesity	0.000399	0.00253	CbGpPWpGaD
Dantrolene—Somnolence—Bupropion—obesity	0.000396	0.0013	CcSEcCtD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—obesity	0.000393	0.00249	CbGpPWpGaD
Dantrolene—Dyspepsia—Bupropion—obesity	0.000392	0.00129	CcSEcCtD
Dantrolene—CYP3A4—Estrogen metabolism—NQO1—obesity	0.000391	0.00248	CbGpPWpGaD
Dantrolene—Hypersensitivity—Orlistat—obesity	0.000389	0.00128	CcSEcCtD
Dantrolene—Decreased appetite—Bupropion—obesity	0.000388	0.00127	CcSEcCtD
Dantrolene—Visual impairment—Topiramate—obesity	0.000385	0.00126	CcSEcCtD
Dantrolene—Fatigue—Bupropion—obesity	0.000384	0.00126	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—TFRC—obesity	0.000382	0.00243	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYB5A—obesity	0.000382	0.00242	CbGpPWpGaD
Dantrolene—Constipation—Bupropion—obesity	0.000381	0.00125	CcSEcCtD
Dantrolene—Pain—Bupropion—obesity	0.000381	0.00125	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—GNB3—obesity	0.00038	0.00241	CbGpPWpGaD
Dantrolene—Asthenia—Orlistat—obesity	0.000379	0.00124	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—HMOX1—obesity	0.000378	0.0024	CbGpPWpGaD
Dantrolene—Hypersensitivity—Sibutramine—obesity	0.000377	0.00123	CcSEcCtD
Dantrolene—Pruritus—Orlistat—obesity	0.000374	0.00122	CcSEcCtD
Dantrolene—Flushing—Topiramate—obesity	0.000371	0.00122	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—GNAS—obesity	0.00037	0.00235	CbGpPWpGaD
Dantrolene—Feeling abnormal—Bupropion—obesity	0.000367	0.0012	CcSEcCtD
Dantrolene—Asthenia—Sibutramine—obesity	0.000367	0.0012	CcSEcCtD
Dantrolene—Gastrointestinal pain—Bupropion—obesity	0.000365	0.00119	CcSEcCtD
Dantrolene—CYP3A4—Xenobiotics—CYP2E1—obesity	0.000364	0.00231	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—APOB—obesity	0.000362	0.0023	CbGpPWpGaD
Dantrolene—Pruritus—Sibutramine—obesity	0.000362	0.00118	CcSEcCtD
Dantrolene—Diarrhoea—Orlistat—obesity	0.000362	0.00118	CcSEcCtD
Dantrolene—Chills—Topiramate—obesity	0.000359	0.00117	CcSEcCtD
Dantrolene—Urticaria—Bupropion—obesity	0.000354	0.00116	CcSEcCtD
Dantrolene—Abdominal pain—Bupropion—obesity	0.000352	0.00115	CcSEcCtD
Dantrolene—Body temperature increased—Bupropion—obesity	0.000352	0.00115	CcSEcCtD
Dantrolene—Diarrhoea—Sibutramine—obesity	0.00035	0.00115	CcSEcCtD
Dantrolene—CYP3A4—Tamoxifen metabolism—CYP2E1—obesity	0.00035	0.00222	CbGpPWpGaD
Dantrolene—Dizziness—Orlistat—obesity	0.000349	0.00114	CcSEcCtD
Dantrolene—Erythema—Topiramate—obesity	0.000348	0.00114	CcSEcCtD
Dantrolene—CYP3A4—Aflatoxin activation and detoxification—GGT1—obesity	0.000348	0.00221	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—obesity	0.000342	0.00217	CbGpPWpGaD
Dantrolene—Tension—Topiramate—obesity	0.000341	0.00112	CcSEcCtD
Dantrolene—Dysgeusia—Topiramate—obesity	0.000341	0.00112	CcSEcCtD
Dantrolene—Dizziness—Sibutramine—obesity	0.000338	0.00111	CcSEcCtD
Dantrolene—Nervousness—Topiramate—obesity	0.000338	0.00111	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—ECHS1—obesity	0.000337	0.00214	CbGpPWpGaD
Dantrolene—Back pain—Topiramate—obesity	0.000337	0.0011	CcSEcCtD
Dantrolene—Vomiting—Orlistat—obesity	0.000336	0.0011	CcSEcCtD
Dantrolene—Rash—Orlistat—obesity	0.000333	0.00109	CcSEcCtD
Dantrolene—Dermatitis—Orlistat—obesity	0.000333	0.00109	CcSEcCtD
Dantrolene—Headache—Orlistat—obesity	0.000331	0.00108	CcSEcCtD
Dantrolene—Hypersensitivity—Bupropion—obesity	0.000328	0.00108	CcSEcCtD
Dantrolene—Vision blurred—Topiramate—obesity	0.000328	0.00107	CcSEcCtD
Dantrolene—CYP3A4—Estrogen metabolism—COMT—obesity	0.000328	0.00208	CbGpPWpGaD
Dantrolene—Vomiting—Sibutramine—obesity	0.000325	0.00106	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC2A4—obesity	0.000325	0.00206	CbGpPWpGaD
Dantrolene—Ill-defined disorder—Topiramate—obesity	0.000323	0.00106	CcSEcCtD
Dantrolene—Rash—Sibutramine—obesity	0.000322	0.00106	CcSEcCtD
Dantrolene—Dermatitis—Sibutramine—obesity	0.000322	0.00106	CcSEcCtD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IL6—obesity	0.000322	0.00204	CbGpPWpGaD
Dantrolene—Anaemia—Topiramate—obesity	0.000322	0.00105	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—CYCS—obesity	0.000321	0.00204	CbGpPWpGaD
Dantrolene—Headache—Sibutramine—obesity	0.00032	0.00105	CcSEcCtD
Dantrolene—Asthenia—Bupropion—obesity	0.00032	0.00105	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—HADH—obesity	0.000317	0.00201	CbGpPWpGaD
Dantrolene—Pruritus—Bupropion—obesity	0.000315	0.00103	CcSEcCtD
Dantrolene—Nausea—Orlistat—obesity	0.000314	0.00103	CcSEcCtD
Dantrolene—Malaise—Topiramate—obesity	0.000314	0.00103	CcSEcCtD
Dantrolene—Leukopenia—Topiramate—obesity	0.000312	0.00102	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—NCOA1—obesity	0.00031	0.00197	CbGpPWpGaD
Dantrolene—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—obesity	0.00031	0.00197	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26B1—obesity	0.000306	0.00194	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—PPARA—obesity	0.000305	0.00194	CbGpPWpGaD
Dantrolene—Diarrhoea—Bupropion—obesity	0.000305	0.000999	CcSEcCtD
Dantrolene—Nausea—Sibutramine—obesity	0.000304	0.000995	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—PLG—obesity	0.000302	0.00192	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP26B1—obesity	0.000302	0.00192	CbGpPWpGaD
Dantrolene—Convulsion—Topiramate—obesity	0.000302	0.000988	CcSEcCtD
Dantrolene—Hypertension—Topiramate—obesity	0.0003	0.000984	CcSEcCtD
Dantrolene—Myalgia—Topiramate—obesity	0.000296	0.00097	CcSEcCtD
Dantrolene—Dizziness—Bupropion—obesity	0.000295	0.000966	CcSEcCtD
Dantrolene—Discomfort—Topiramate—obesity	0.000293	0.000959	CcSEcCtD
Dantrolene—Dry mouth—Topiramate—obesity	0.00029	0.000949	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—APOA1—obesity	0.000287	0.00182	CbGpPWpGaD
Dantrolene—Confusional state—Topiramate—obesity	0.000286	0.000938	CcSEcCtD
Dantrolene—Vomiting—Bupropion—obesity	0.000283	0.000928	CcSEcCtD
Dantrolene—Rash—Bupropion—obesity	0.000281	0.000921	CcSEcCtD
Dantrolene—Dermatitis—Bupropion—obesity	0.000281	0.00092	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—GNB3—obesity	0.00028	0.00178	CbGpPWpGaD
Dantrolene—Headache—Bupropion—obesity	0.000279	0.000915	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—HMOX1—obesity	0.000279	0.00177	CbGpPWpGaD
Dantrolene—Thrombocytopenia—Topiramate—obesity	0.000278	0.000911	CcSEcCtD
Dantrolene—Tachycardia—Topiramate—obesity	0.000277	0.000908	CcSEcCtD
Dantrolene—Hyperhidrosis—Topiramate—obesity	0.000275	0.000899	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—GNAS—obesity	0.000273	0.00173	CbGpPWpGaD
Dantrolene—Anorexia—Topiramate—obesity	0.000271	0.000887	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—APOB—obesity	0.000267	0.00169	CbGpPWpGaD
Dantrolene—Nausea—Bupropion—obesity	0.000265	0.000867	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Topiramate—obesity	0.000259	0.000848	CcSEcCtD
Dantrolene—Insomnia—Topiramate—obesity	0.000257	0.000841	CcSEcCtD
Dantrolene—Somnolence—Topiramate—obesity	0.000252	0.000827	CcSEcCtD
Dantrolene—Dyspepsia—Topiramate—obesity	0.00025	0.000819	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP26B1—obesity	0.000248	0.00157	CbGpPWpGaD
Dantrolene—Decreased appetite—Topiramate—obesity	0.000247	0.000809	CcSEcCtD
Dantrolene—Fatigue—Topiramate—obesity	0.000245	0.000802	CcSEcCtD
Dantrolene—Constipation—Topiramate—obesity	0.000243	0.000795	CcSEcCtD
Dantrolene—Pain—Topiramate—obesity	0.000243	0.000795	CcSEcCtD
Dantrolene—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—obesity	0.000241	0.00153	CbGpPWpGaD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—obesity	0.000238	0.00151	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL6—obesity	0.000237	0.00151	CbGpPWpGaD
Dantrolene—Feeling abnormal—Topiramate—obesity	0.000234	0.000767	CcSEcCtD
Dantrolene—Gastrointestinal pain—Topiramate—obesity	0.000232	0.000761	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—ALB—obesity	0.000227	0.00144	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—obesity	0.000226	0.00143	CbGpPWpGaD
Dantrolene—Urticaria—Topiramate—obesity	0.000226	0.000739	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—PPARA—obesity	0.000225	0.00143	CbGpPWpGaD
Dantrolene—Abdominal pain—Topiramate—obesity	0.000225	0.000735	CcSEcCtD
Dantrolene—Body temperature increased—Topiramate—obesity	0.000225	0.000735	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—obesity	0.000217	0.00138	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—APOA1—obesity	0.000211	0.00134	CbGpPWpGaD
Dantrolene—Hypersensitivity—Topiramate—obesity	0.000209	0.000685	CcSEcCtD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—obesity	0.000204	0.0013	CbGpPWpGaD
Dantrolene—Asthenia—Topiramate—obesity	0.000204	0.000667	CcSEcCtD
Dantrolene—Pruritus—Topiramate—obesity	0.000201	0.000658	CcSEcCtD
Dantrolene—Diarrhoea—Topiramate—obesity	0.000194	0.000636	CcSEcCtD
Dantrolene—Dizziness—Topiramate—obesity	0.000188	0.000615	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—CYP2E1—obesity	0.000187	0.00119	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—obesity	0.000184	0.00117	CbGpPWpGaD
Dantrolene—Vomiting—Topiramate—obesity	0.000181	0.000591	CcSEcCtD
Dantrolene—Rash—Topiramate—obesity	0.000179	0.000587	CcSEcCtD
Dantrolene—Dermatitis—Topiramate—obesity	0.000179	0.000586	CcSEcCtD
Dantrolene—Headache—Topiramate—obesity	0.000178	0.000583	CcSEcCtD
Dantrolene—Nausea—Topiramate—obesity	0.000169	0.000553	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—ALB—obesity	0.000167	0.00106	CbGpPWpGaD
Dantrolene—CYP3A4—Tryptophan metabolism—CYP19A1—obesity	0.000167	0.00106	CbGpPWpGaD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—obesity	0.000156	0.000992	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—obesity	0.000151	0.000959	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—obesity	0.000149	0.000946	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—obesity	0.000137	0.000867	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—obesity	0.000135	0.000855	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—obesity	0.000133	0.000843	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP26B1—obesity	0.000132	0.000836	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP26B1—obesity	0.00013	0.000824	CbGpPWpGaD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—obesity	0.000129	0.00082	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—obesity	0.000122	0.000777	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—ADH1B—obesity	0.000115	0.000733	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—obesity	0.000111	0.000703	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—obesity	0.000109	0.000693	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—SULT2A1—obesity	8.9e-05	0.000565	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—SULT2A1—obesity	8.77e-05	0.000557	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GPX3—obesity	8.37e-05	0.000531	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—obesity	8.09e-05	0.000514	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—AKR1C3—obesity	7.34e-05	0.000466	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—obesity	6.56e-05	0.000416	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP2E1—obesity	6.5e-05	0.000413	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP2E1—obesity	6.42e-05	0.000407	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GGT1—obesity	5.97e-05	0.000379	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—NCOA1—obesity	5.88e-05	0.000373	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP19A1—obesity	5.8e-05	0.000368	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP19A1—obesity	5.72e-05	0.000363	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CA3—obesity	5.42e-05	0.000344	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—COMT—obesity	5.39e-05	0.000342	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—COMT—obesity	5.32e-05	0.000337	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GLRX—obesity	4.61e-05	0.000293	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—OTC—obesity	4.11e-05	0.000261	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPM1L—obesity	4.11e-05	0.000261	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ETFDH—obesity	4.11e-05	0.000261	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—INSIG2—obesity	4.11e-05	0.000261	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—UQCRC2—obesity	3.76e-05	0.000239	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GPT—obesity	3.76e-05	0.000239	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—INPP5E—obesity	3.76e-05	0.000239	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SUCLG2—obesity	3.5e-05	0.000222	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALDH6A1—obesity	3.5e-05	0.000222	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ME1—obesity	3.5e-05	0.000222	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—POMC—obesity	3.48e-05	0.000221	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—UCP1—obesity	3.29e-05	0.000209	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—COX7C—obesity	3.29e-05	0.000209	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PNPLA3—obesity	3.29e-05	0.000209	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CS—obesity	3.12e-05	0.000198	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—DGAT2—obesity	3.12e-05	0.000198	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SUCLA2—obesity	3.12e-05	0.000198	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CPS1—obesity	3.12e-05	0.000198	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LIPE—obesity	2.97e-05	0.000189	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—MUT—obesity	2.97e-05	0.000189	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—DGAT1—obesity	2.85e-05	0.000181	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYB5A—obesity	2.85e-05	0.000181	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ACLY—obesity	2.74e-05	0.000174	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ENPP1—obesity	2.65e-05	0.000168	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALOX12—obesity	2.65e-05	0.000168	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HMGCS1—obesity	2.57e-05	0.000163	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PLIN1—obesity	2.49e-05	0.000158	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PNPLA2—obesity	2.49e-05	0.000158	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PFKFB3—obesity	2.49e-05	0.000158	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SAT1—obesity	2.49e-05	0.000158	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ACADM—obesity	2.49e-05	0.000158	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ANGPTL4—obesity	2.49e-05	0.000158	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—OXCT1—obesity	2.42e-05	0.000154	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYTB—obesity	2.42e-05	0.000154	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ACACB—obesity	2.42e-05	0.000154	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PNLIP—obesity	2.36e-05	0.00015	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SRD5A1—obesity	2.36e-05	0.00015	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SDC3—obesity	2.3e-05	0.000146	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—STS—obesity	2.25e-05	0.000143	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HK2—obesity	2.25e-05	0.000143	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP26B1—obesity	2.25e-05	0.000143	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPARD—obesity	2.2e-05	0.00014	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC27A1—obesity	2.16e-05	0.000137	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—FABP4—obesity	2.12e-05	0.000134	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GLUL—obesity	2.12e-05	0.000134	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HSD11B1—obesity	2.01e-05	0.000127	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—UCP3—obesity	2.01e-05	0.000127	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—UCP2—obesity	2.01e-05	0.000127	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ECHS1—obesity	2.01e-05	0.000127	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ADH1B—obesity	1.97e-05	0.000125	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GPAM—obesity	1.94e-05	0.000123	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ACSL1—obesity	1.94e-05	0.000123	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPARGC1B—obesity	1.94e-05	0.000123	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—FADS1—obesity	1.89e-05	0.00012	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HADH—obesity	1.89e-05	0.00012	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PCK1—obesity	1.89e-05	0.00012	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ACP5—obesity	1.84e-05	0.000117	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—G6PD—obesity	1.79e-05	0.000114	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HK1—obesity	1.77e-05	0.000112	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SREBF2—obesity	1.77e-05	0.000112	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LPA—obesity	1.71e-05	0.000108	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LPIN1—obesity	1.67e-05	0.000106	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOA5—obesity	1.64e-05	0.000104	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC22A1—obesity	1.56e-05	9.91e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CLOCK—obesity	1.56e-05	9.91e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SULT2A1—obesity	1.52e-05	9.66e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GLP1R—obesity	1.52e-05	9.66e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—DPYD—obesity	1.5e-05	9.5e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PRKAR2B—obesity	1.44e-05	9.14e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—DCN—obesity	1.43e-05	9.08e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CPT1A—obesity	1.39e-05	8.83e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NAMPT—obesity	1.36e-05	8.66e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LIPC—obesity	1.36e-05	8.61e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GCK—obesity	1.36e-05	8.61e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOC3—obesity	1.35e-05	8.55e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CETP—obesity	1.31e-05	8.3e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SDC1—obesity	1.29e-05	8.21e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AKR1C3—obesity	1.27e-05	8.08e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SCARB1—obesity	1.25e-05	7.95e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SREBF1—obesity	1.22e-05	7.72e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GOT2—obesity	1.18e-05	7.51e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—FASN—obesity	1.16e-05	7.35e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—BCHE—obesity	1.15e-05	7.32e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP2E1—obesity	1.11e-05	7.06e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NQO1—obesity	1.1e-05	6.98e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GCG—obesity	1.05e-05	6.69e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC2A4—obesity	1.05e-05	6.69e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYCS—obesity	1.04e-05	6.61e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GGT1—obesity	1.02e-05	6.48e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GOT1—obesity	1.02e-05	6.48e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NCOA1—obesity	1.01e-05	6.39e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—STK11—obesity	9.91e-06	6.29e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP19A1—obesity	9.91e-06	6.29e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—COMT—obesity	9.22e-06	5.85e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GNB3—obesity	9.09e-06	5.77e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPARGC1A—obesity	9.09e-06	5.77e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HMOX1—obesity	9.05e-06	5.74e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GNAS—obesity	8.85e-06	5.62e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOB—obesity	8.67e-06	5.5e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LPL—obesity	8.27e-06	5.25e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GPX1—obesity	8.07e-06	5.12e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CD36—obesity	7.86e-06	4.99e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—MTHFR—obesity	7.45e-06	4.73e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPARA—obesity	7.31e-06	4.64e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AGT—obesity	7.08e-06	4.49e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOE—obesity	6.94e-06	4.4e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CAV1—obesity	6.87e-06	4.36e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOA1—obesity	6.86e-06	4.35e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3CG—obesity	6.26e-06	3.97e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPARG—obesity	6.04e-06	3.83e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—POMC—obesity	5.96e-06	3.78e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—INS—obesity	5.93e-06	3.76e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3CD—obesity	5.5e-06	3.49e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALB—obesity	5.43e-06	3.45e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3R1—obesity	5.2e-06	3.3e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NOS3—obesity	5.2e-06	3.3e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3CB—obesity	4.8e-06	3.04e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PTGS2—obesity	4.75e-06	3.02e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3CA—obesity	2.92e-06	1.86e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AKT1—obesity	2.39e-06	1.52e-05	CbGpPWpGaD
